UDG Healthcare PLC (LON:UDG) has announced the acquisition of two US-based businesses, Create NYC and SmartAnalyst, for a combined consideration of up to US$82.4mln.
The FTSE 250-listed firm said both companies are dedicated to the healthcare market.
The company said Create NYC is an innovative New York-based healthcare creative communications agency, and SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector.
UDG Healthcare said both transactions will be financed from existing cash and debt facilities and are expected to be earnings accretive.
In a separate statement, the company has announced the appointment of Erik Van Snippenberg as a non-executive director of the company with effect from 2 July 2018.
The company said Erik Van Snippenberg spend almost thirty years at GlaxoSmithKline and also has extensive experience in products launches, product lifecycle management, business development and strategy.